Yi-Jun Gong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yi-Jun Gong has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Qian Wang
5 shared publications- Guisheng Zhang
Henan Normal University
4 shared publications Aiying Ma
3 shared publicationsWenxue Shi
3 shared publicationsDan−Dan Feng
School of Chemistry and Chemical Engineering, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Henan Normal University, Xinxiang, Henan, 453007, China
2 shared publicationsGuisheng Zhang
Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Collaborative Innovation Centre of Henan Province for Green Manufacturing of Fine Chemicals, Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, Henan International Joint Laboratory of Smart Molecules and Identification and Diagnostic Functions, School of Chemistry and Chemical Engineering
2 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1
Correction to: An excitation‑customized ICT‑type turn‑on probe for visualization of cysteine fluctuation in diverse drug‑induced ferroptosis pathways
- 24 September 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1
Open AccessCorrection to: An excitation‑customized ICT‑type turn‑on probe for visualization of cysteine fluctuation in diverse drug‑induced ferroptosis pathways
- 5 September 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1-14
An excitation-customized ICT-type turn-on probe for visualization of cysteine fluctuation in diverse drug-induced ferroptosis pathways
Cysteine (Cys) acts as a key upstream regulator of cellular redox homeostasis and ferroptosis. Distinct ferroptosis inducers exert different effects on Cys metabolism. Erastin disrupts Xc−-dependent cystine uptake to deplete cellular Cys and trigger ferroptosis, while RSL3 induces ferroptosis by impairing downstream lipid metabolism without disturbing Cys homeostasis. Thus, real-time monitoring of Cys fluctuations is vital for distinguishing early ferroptosis initiation from downstream cascades. Conventional PET-type turn-on fluorescent probes suffer from high background and poor sensitivity. Herein, we report an excitation-customized strategy to develop ICT-type turn-on probe for Cys sensing. Based on a series of chalcogen-regulated near-infrared hemicyanine dyes, a selenium-substituted fluorophore HDXZ was screened out to construct the Cys-specific probe BXXZ. Under the customized excitation, BXXZ exhibited high fluorescence enhancement (66-fold), a low detection limit (0.23 μM), fast response, and excellent selectivity for Cys over Hcy and GSH. Benefiting from these merits, BXXZ enabled real-time visualization of differential Cys fluctuation in ferroptosis induced by erastin and RSL3, and achieved in situ tracking of intratumoral Cys fluctuation in HepG2 xenograft models. This work provides a feasible design strategy for high-quality ICT-type turn-on probes and a powerful imaging tool to explore the relationship between Cys homeostasis and ferroptosis. Graphical Abstract
- 5 September 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1-14
An excitation-customized ICT-type turn-on probe for visualization of cysteine fluctuation in diverse drug-induced ferroptosis pathways
Cysteine (Cys) acts as a key upstream regulator of cellular redox homeostasis and ferroptosis. Distinct ferroptosis inducers exert different effects on Cys metabolism. Erastin disrupts Xc−-dependent cystine uptake to deplete cellular Cys and trigger ferroptosis, while RSL3 induces ferroptosis by impairing downstream lipid metabolism without disturbing Cys homeostasis. Thus, real-time monitoring of Cys fluctuations is vital for distinguishing early ferroptosis initiation from downstream cascades. Conventional PET-type turn-on fluorescent probes suffer from high background and poor sensitivity. Herein, we report an excitation-customized strategy to develop ICT-type turn-on probe for Cys sensing. Based on a series of chalcogen-regulated near-infrared hemicyanine dyes, a selenium-substituted fluorophore HDXZ was screened out to construct the Cys-specific probe BXXZ. Under the customized excitation, BXXZ exhibited high fluorescence enhancement (66-fold), a low detection limit (0.23 μM), fast response, and excellent selectivity for Cys over Hcy and GSH. Benefiting from these merits, BXXZ enabled real-time visualization of differential Cys fluctuation in ferroptosis induced by erastin and RSL3, and achieved in situ tracking of intratumoral Cys fluctuation in HepG2 xenograft models. This work provides a feasible design strategy for high-quality ICT-type turn-on probes and a powerful imaging tool to explore the relationship between Cys homeostasis and ferroptosis. Graphical Abstract
- 13 April 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (37) , 9486-9490
peri -Selective C–H activation-initiated spiroannulation leading to spiropolycyclic compounds with unique photophysical properties and strong anticancer activity
Presented herein is a peri -selective spiroannulation of 3-(naphthalen-1-yl)-2 H -indazoles with cyclic diazo compounds leading to the formation of benzo[ de ]isoquinoline spiroisoquinolinone and benzo[ de ]isoquinoline spironaphthalenone derivatives.
- 13 April 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (37) , 9486-9490
peri -Selective C–H activation-initiated spiroannulation leading to spiropolycyclic compounds with unique photophysical properties and strong anticancer activity
Presented herein is a peri -selective spiroannulation of 3-(naphthalen-1-yl)-2 H -indazoles with cyclic diazo compounds leading to the formation of benzo[ de ]isoquinoline spiroisoquinolinone and benzo[ de ]isoquinoline spironaphthalenone derivatives.
- 3 April 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (15) , 5244-5258
Synthesis of Indazole Fused 2-Benzazepines with Polarity-Dependent Fluorescence Based on Formal [4 + 3] Annulation of 3-Aryl-1H-indazoles with Cyclopropenones
The effective assembly of benzazepine skeletons in a sustainable and atom-economical fashion remains a challenging goal in modern organic synthesis. Presented herein is a novel synthesis of indazole fused 2-benzazepine derivatives based on a formal [4 + 3] annulation of 3-aryl-1H-indazoles with cyclopropenones. The formation of products proceeds through Ir(III)-catalyzed aryl C-H bond metalation and cyclopropenone ring-opening leading to aryl acylation, followed by an intramolecular N-nucleophilic conjugated addition. By using this method, a number of valuable benzazepine derivatives were effectively generated. This protocol addresses the challenges in constructing medium-sized rings through cascade C-H/C-C bond activation and C-C/C-N bond formation. Moreover, the photophysical properties of the products thus obtained were also evaluated. It turned out that all compounds tested showed solvent polarity-dependent fluorescence features, which could be potentially applied for revealing the polarity of their immediate environments.
- 3 April 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (15) , 5244-5258
Synthesis of Indazole Fused 2-Benzazepines with Polarity-Dependent Fluorescence Based on Formal [4 + 3] Annulation of 3-Aryl-1H-indazoles with Cyclopropenones
The effective assembly of benzazepine skeletons in a sustainable and atom-economical fashion remains a challenging goal in modern organic synthesis. Presented herein is a novel synthesis of indazole fused 2-benzazepine derivatives based on a formal [4 + 3] annulation of 3-aryl-1H-indazoles with cyclopropenones. The formation of products proceeds through Ir(III)-catalyzed aryl C-H bond metalation and cyclopropenone ring-opening leading to aryl acylation, followed by an intramolecular N-nucleophilic conjugated addition. By using this method, a number of valuable benzazepine derivatives were effectively generated. This protocol addresses the challenges in constructing medium-sized rings through cascade C-H/C-C bond activation and C-C/C-N bond formation. Moreover, the photophysical properties of the products thus obtained were also evaluated. It turned out that all compounds tested showed solvent polarity-dependent fluorescence features, which could be potentially applied for revealing the polarity of their immediate environments.
- 19 January 2025
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 429
A two-step recognition fluorescent probe for ultra-wide range detection of SO2 in food and water samples
- 19 January 2025
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 429
A two-step recognition fluorescent probe for ultra-wide range detection of SO2 in food and water samples
- Top Cited Papers
- 15 January 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 1032-1042
Hypochlorous Acid-Activatable NIR Fluorescence/Photoacoustic Dual-Modal Probe with High Signal-to-Background Ratios for Imaging of Liver Injury and Plasma Diagnosis of Sepsis
Hypochlorous acid can be employed as a biomarker for blood infection (such as sepsis) and tissue damage (such as drug-induced liver injury, DILI), and the diagnosis of tissue damage or blood infection can be achieved through the detection of hypochlorous acid in relevant biological samples. Considering the complex environment and the diverse interferences in living organisms and blood plasma, developing new detection methods for HClO with high signal-to-background ratios is particularly important, and it can improve the accuracy of detection and quality of imaging based on a higher contrast, which makes the detection of HClO clearer and more accurate. Here, based on the advantages of the NIR fluorescence/photoacoustic dual-modal probe, we reported a hypochlorous acid-activatable NIR fluorescence/photoacoustic dual-modal probe (NIRF-PA-HClO) based on the spirolactam ring-opening strategy in this paper. NIRF-PA-HClO showed excellent NIRF/PA dual-modal responses with high SBRs for HClO in solution, cells, and mice. Moreover, NIRF-PA-HClO was successfully applied for high-contrast imaging of DILI. Finally, NIRF-PA-HClO was employed for the blood plasma diagnosis of sepsis with satisfactory results. In summary, the above results proved that NIRF-PA-HClO would be a potentially useful tool for the study of physiological and pathological roles of HClO, the investigation of the pathology and therapeutic mechanisms of hepatotoxicity, and the diagnosis of blood infection. Also, the development of NIRF-PA-HClO provides new design mentality for constructing other analyte-activatable NIRF/PA dual-modal probes with high SBRs.
- 15 January 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 1032-1042
Top Cited PapersHypochlorous Acid-Activatable NIR Fluorescence/Photoacoustic Dual-Modal Probe with High Signal-to-Background Ratios for Imaging of Liver Injury and Plasma Diagnosis of Sepsis
Hypochlorous acid can be employed as a biomarker for blood infection (such as sepsis) and tissue damage (such as drug-induced liver injury, DILI), and the diagnosis of tissue damage or blood infection can be achieved through the detection of hypochlorous acid in relevant biological samples. Considering the complex environment and the diverse interferences in living organisms and blood plasma, developing new detection methods for HClO with high signal-to-background ratios is particularly important, and it can improve the accuracy of detection and quality of imaging based on a higher contrast, which makes the detection of HClO clearer and more accurate. Here, based on the advantages of the NIR fluorescence/photoacoustic dual-modal probe, we reported a hypochlorous acid-activatable NIR fluorescence/photoacoustic dual-modal probe (NIRF-PA-HClO) based on the spirolactam ring-opening strategy in this paper. NIRF-PA-HClO showed excellent NIRF/PA dual-modal responses with high SBRs for HClO in solution, cells, and mice. Moreover, NIRF-PA-HClO was successfully applied for high-contrast imaging of DILI. Finally, NIRF-PA-HClO was employed for the blood plasma diagnosis of sepsis with satisfactory results. In summary, the above results proved that NIRF-PA-HClO would be a potentially useful tool for the study of physiological and pathological roles of HClO, the investigation of the pathology and therapeutic mechanisms of hepatotoxicity, and the diagnosis of blood infection. Also, the development of NIRF-PA-HClO provides new design mentality for constructing other analyte-activatable NIRF/PA dual-modal probes with high SBRs.
- 13 January 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (8) , 2767-2775
A steric hindrance-regulated probe with single excitation dual emissions for self-adaptive detection of biothiols and H 2 S in human urine samples and living cells
A steric-hindrance regulated probe NBD-2FDCI for self-adaptive detection of biothiols and H 2 S in human urine and living cells.
- 13 January 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (8) , 2767-2775
A steric hindrance-regulated probe with single excitation dual emissions for self-adaptive detection of biothiols and H 2 S in human urine samples and living cells
A steric-hindrance regulated probe NBD-2FDCI for self-adaptive detection of biothiols and H 2 S in human urine and living cells.
- 24 April 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (18) , 7248-7256
NIR Fluorescent/Photoacoustic Bimodal Imaging of Ferroptosis in Pancreatic Cancer Using Biothiols-Activable Probes
Ferroptosis modulation is a powerful therapeutic option for pancreatic ductal adenocarcinoma (PDAC) with a low 5-year survival rate and lack of effective treatment methods. However, due to the dual role of ferroptosis in promoting and inhibiting pancreatic tumorigenesis, regulating the degree of ferroptosis is very important to obtain the best therapeutic effect of PDAC. Biothiols are suitable as biomarkers of imaging ferroptosis due to the dramatic decreases of biothiol levels in ferroptosis caused by the inhibited synthesis pathway of glutathione (GSH) and the depletion of biothiol by reactive oxygen species. Moreover, a very recent study reported that cysteine (Cys) depletion can lead to pancreatic tumor ferroptosis in mice and may be employed as an effective therapeutic strategy for PDAC. Therefore, visualization of biothiols in ferroptosis of PDAC will be helpful for regulating the degree of ferroptosis, understanding the mechanism of Cys depletion-induced pancreatic tumor ferroptosis, and further promoting the study and treatment of PDAC. Herein, two biothiol-activable near-infrared (NIR) fluorescent/photoacoustic bimodal imaging probes (HYD-BX and HYD-DX) for imaging of pancreatic tumor ferroptosis were reported. These two probes show excellent bimodal response performances for biothiols in solution, cells, and tumors. Subsequently, they have been employed successfully for real-time visualization of changes in concentration levels of biothiols during the ferroptosis process in PDAC cells and HepG2 cells. Most importantly, they have been further applied for bimodal imaging of ferroptosis in pancreatic cancer in mice, with satisfactory results. The development of these two probes provides new tools for monitoring changes in concentration levels of biothiols in ferroptosis and will have a positive impact on understanding the mechanism of Cys depletion-induced pancreatic tumor ferroptosis and further promoting the study and treatment of PDAC.
- 24 April 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (18) , 7248-7256
NIR Fluorescent/Photoacoustic Bimodal Imaging of Ferroptosis in Pancreatic Cancer Using Biothiols-Activable Probes
Ferroptosis modulation is a powerful therapeutic option for pancreatic ductal adenocarcinoma (PDAC) with a low 5-year survival rate and lack of effective treatment methods. However, due to the dual role of ferroptosis in promoting and inhibiting pancreatic tumorigenesis, regulating the degree of ferroptosis is very important to obtain the best therapeutic effect of PDAC. Biothiols are suitable as biomarkers of imaging ferroptosis due to the dramatic decreases of biothiol levels in ferroptosis caused by the inhibited synthesis pathway of glutathione (GSH) and the depletion of biothiol by reactive oxygen species. Moreover, a very recent study reported that cysteine (Cys) depletion can lead to pancreatic tumor ferroptosis in mice and may be employed as an effective therapeutic strategy for PDAC. Therefore, visualization of biothiols in ferroptosis of PDAC will be helpful for regulating the degree of ferroptosis, understanding the mechanism of Cys depletion-induced pancreatic tumor ferroptosis, and further promoting the study and treatment of PDAC. Herein, two biothiol-activable near-infrared (NIR) fluorescent/photoacoustic bimodal imaging probes (HYD-BX and HYD-DX) for imaging of pancreatic tumor ferroptosis were reported. These two probes show excellent bimodal response performances for biothiols in solution, cells, and tumors. Subsequently, they have been employed successfully for real-time visualization of changes in concentration levels of biothiols during the ferroptosis process in PDAC cells and HepG2 cells. Most importantly, they have been further applied for bimodal imaging of ferroptosis in pancreatic cancer in mice, with satisfactory results. The development of these two probes provides new tools for monitoring changes in concentration levels of biothiols in ferroptosis and will have a positive impact on understanding the mechanism of Cys depletion-induced pancreatic tumor ferroptosis and further promoting the study and treatment of PDAC.